Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
Neuroharmonics is developing a non-invasive neuromodulation platform based on focused transcranial ultrasound to modulate specific brain circuits for treating neurological and psychiatric conditions and enabling brain-computer interaction. The company operates in the neurotech and medical technology space.
2 investors
NeuroIntact develops VCool, a portable system for precise core body temperature modulation in hospitalized patients. The company serves clinical markets including military and commercial hospitals, operating in the medical device and healthcare technology sector.
2 investors
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.
2 investors
Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services. The product aims to make epilepsy diagnostics more efficient and enable earlier, more accurate diagnoses.
2 investors
NeuroSonic develops a handheld, non-invasive device that assesses stroke risk by analyzing carotid artery blood flow, enabling clinicians to determine which patients require further vascular imaging. The device is designed for use in clinical settings to accelerate stroke-risk assessment and improve prevention.
2 investors
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
2 investors
NeuroWyzr is a clinical neuroscience company that builds gamified digital assessments and care products for early detection, diagnosis, monitoring and prevention of brain decline. Its offerings use clinical evidence and AI-powered analytics to support brain health and mental wellbeing, with a focus on the Asia-Pacific market.
2 investors
Nevro develops spinal cord stimulation systems for pain management, offering the Senza Trial Stimulator with high-frequency therapy options and wireless capability for patient trials and treatment.
2 investors
New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures. The company targets healthcare systems seeking to reduce costs while improving clinical outcomes.
2 investors
Shanghai NewMed Medical is a Chinese medical device company founded in 2015 that develops, manufactures, and sells transcatheter artificial heart valves and interventional ventricular assist systems. Its products target interventional treatment of cardiovascular disease for clinicians and patients in China.
2 investors
New Path Molecular develops drug conjugates targeting phosphatidylserine on cancer cell membranes to treat solid tumors with reduced toxicity to healthy tissue. The company's lead program, PDC-1, is designed to treat colorectal and pancreatic cancer and is advancing toward clinical candidate selection.
2 investors
NEX builds artificial intelligence systems to help hospitals detect, track, and prevent healthcare-associated infections by analyzing connections between people, places, and transmission pathways. The platform serves hospital infection prevention, microbiology, and clinical teams to shift from reactive surveillance to proactive prevention.
2 investors
NexImmune is a biotechnology company developing antigen-directed immunotherapies based on its proprietary AIM nanoparticle platform, which mimics dendritic cell signaling to activate antigen-specific T cell responses. Its programs target oncology, autoimmune disorders, and infectious disease using formats including adoptive cell therapy (AIM ACT) and direct injection (AIM INJ).
2 investors
NextStep Robotics develops AMBLE, a wearable robotic device for foot drop rehabilitation in stroke survivors and other neurological conditions. The device combines robotics and algorithms to provide graded assistance for gait retraining in clinical rehabilitation settings.
2 investors
NFlection is a biopharmaceutical company developing novel therapeutics. The page does not state what the company's specific products or therapeutic focus are.
2 investors
Nibec is a South Korean biotech company that develops peptide-based therapeutics and dental biomaterials, including bone graft materials, periodontal tissue regeneration products, tooth-whitening agents, and drug-delivery platforms. It supplies materials to global implant and pharmaceutical companies and pursues clinical development of treatments for conditions such as pulmonary fibrosis and inflammatory bowel disease.
2 investors
Nicolab builds StrokeViewer, an AI-powered, cloud-based platform for acute care teams that speeds up stroke triage by giving physicians fast access to DICOM imaging, patient timelines, and secure messaging across hospitals. It serves clinicians such as neuroradiologists in the stroke care workflow, with detection support for occlusions (LVO) and intracranial hemorrhage.
2 investors
NIRA develops at-home laser devices for skincare that deliver professional-grade results without pain or downtime, using patented semiconductor laser technology originally developed for dermatological clinics. The company manufactures its FDA-cleared devices in the USA and targets consumers seeking accessible professional skincare treatments.
2 investors
Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties. The software is designed to run on standard and handheld ultrasound devices for use by clinicians and neurosurgeons treating brain injury and neurological conditions.
2 investors
Nitinotes is an early-commercial-stage medical device company that makes EndoZip, an automated endoscopic suturing system for gastroplasty used to treat class I and II obesity in patients who do not qualify for traditional bariatric surgery. The device targets gastroenterologists and bariatric endoscopy units performing minimally invasive weight-loss procedures.
2 investors
Nivaan is India's largest centre for interventional pain management and regenerative medicine, offering integrated, non-surgical care for musculoskeletal and chronic pain through coordinated multidisciplinary teams of specialists, physiotherapists, and care managers.
2 investors
NKA Bio develops antibody-based medicines for critically ill and trauma patients to extend survival time during medical emergencies. The company's lead candidate, NKA01, is an anti-shock toxin antibody administered by emergency medical services to stabilize trauma patients and buy time for transport and surgical intervention.
2 investors
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions. Its lead candidate, ignaseclant (NMD670), is in clinical development for Charcot-Marie-Tooth disease, generalized myasthenia gravis, and spinal muscular atrophy.</parameter> <parameter name="founders">[]
2 investors
Noah Labs develops AI-powered algorithms and telemonitoring software for early detection of cardiac decompensation and heart failure management in clinical settings. The company's technology integrates external medical devices and algorithms to enable remote patient monitoring for healthcare providers.
2 investors